Caris Life Sciences Company

Caris Molecular Intelligence revolutionizes precision medicine to provide physicians and patients with information about their health. They develop Caris Molecular Intelligence Services that does panomic molecular profiling for oncology. Caris Life Sciences was founded with a very simple but powerful purpose – to help improve the lives of as manypeople as possible. Through tireless efforts, breakthrough molecular science, and a passionate commitment to quality, they remain steadfastly focused on the most important part of their work – the patient.

Funding Status: Private Equity
Estimated Revenue: $100M to $500M
Technology: Genetic Test & Molecular Diagnostics
Founded Date: 01.01.1996
Headquarters: Basel
Industry: P4 Medicine